These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3083877)

  • 1. Long-term effects of combined vitamin B6-magnesium administration in an autistic child.
    Martineau J; Barthelemy C; Lelord G
    Biol Psychiatry; 1986 May; 21(5-6):511-8. PubMed ID: 3083877
    [No Abstract]   [Full Text] [Related]  

  • 2. Brief report: an open middle-term study of combined vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment.
    Martineau J; Barthelemy C; Cheliakine C; Lelord G
    J Autism Dev Disord; 1988 Sep; 18(3):435-47. PubMed ID: 3170459
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children.
    Lelord G; Callaway E; Muh JP
    Acta Vitaminol Enzymol; 1982; 4(1-2):27-44. PubMed ID: 7124567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vitamin B6 on averaged evoked potentials in infantile autism.
    Martineau J; Garreau B; Barthelemy C; Callaway E; Lelord G
    Biol Psychiatry; 1981 Jul; 16(7):627-41. PubMed ID: 7272379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.
    Martineau J; Barthelemy C; Garreau B; Lelord G
    Biol Psychiatry; 1985 May; 20(5):467-78. PubMed ID: 3886023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological and clinical effects of oral magnesium and associated magnesium-vitamin B6 administration on certain disorders observed in infantile autism (author's transl)].
    Barthelemy C; Garreau B; Leddet I; Sauvage D; Domenech J; Muh JP; Lelord G
    Therapie; 1980; 35(5):627-32. PubMed ID: 7010662
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of behavior scales and urinary homovanillic acid determinations in monitoring the combined treatment with vitamin B6 and magnesium of children displaying autistic behavior].
    Barthélémy C; Garreau B; Leddet I; Sauvage D; Muh JP; Lelord G; Callaway E
    Neuropsychiatr Enfance Adolesc; 1983; 31(5-6):289-301. PubMed ID: 6888687
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour.
    Martineau J; Barthelemy C; Roux S; Garreau B; Lelord G
    Dev Med Child Neurol; 1989 Dec; 31(6):721-7. PubMed ID: 2599266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modifications in urinary homovanillic acid after ingestion of vitamin B6; functional study in autistic children (author's transl)].
    Lelord G; Callaway E; Muh JP; Arlot JC; Sauvage D; Garreau B; Domenech J
    Rev Neurol (Paris); 1978 Dec; 134(12):797-801. PubMed ID: 754238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study.
    Rimland B; Callaway E; Dreyfus P
    Am J Psychiatry; 1978 Apr; 135(4):472-5. PubMed ID: 345827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and biochemical value of Magnesium + vitamin B6 combination in the treatment of residual autism in adults].
    Jonas C; Etienne T; Barthélemy C; Jouve J; Mariotte N
    Therapie; 1984; 39(6):661-9. PubMed ID: 6397868
    [No Abstract]   [Full Text] [Related]  

  • 12. Critique of "Efficacy of vitamin B6 and magnesium in the treatment of autism".
    Rimland B
    J Autism Dev Disord; 1998 Dec; 28(6):580-1. PubMed ID: 9932246
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of pyridoxine and magnesium on autistic symptoms--initial observations.
    Lelord G; Muh JP; Barthelemy C; Martineau J; Garreau B; Callaway E
    J Autism Dev Disord; 1981 Jun; 11(2):219-30. PubMed ID: 6765503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose vitamin B6 and magnesium in treating autism: response to study by Findling et al.
    Rimland B
    J Autism Dev Disord; 1998 Dec; 28(6):581-2. PubMed ID: 9932247
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes.
    Pfeiffer SI; Norton J; Nelson L; Shott S
    J Autism Dev Disord; 1995 Oct; 25(5):481-93. PubMed ID: 8567594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory evoked potential modifications according to clinical and biochemical responsiveness to fenfluramine treatment in children with autistic behavior.
    Bruneau N; Barthélémy C; Roux S; Jouve J; Lelord G
    Neuropsychobiology; 1989; 21(1):48-52. PubMed ID: 2682347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental changes in ERPs and monoamine metabolites in normal, mentally retarded and autistic children.
    Martineau J; Bruneau N; Barthelemy C; Garreau B; Muh JP; Lelord G
    Electroencephalogr Clin Neurophysiol Suppl; 1987; 40():609-16. PubMed ID: 3480182
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversies in the treatment of autistic children: vitamin and drug therapy.
    Rimland B
    J Child Neurol; 1988; 3 Suppl():S68-72. PubMed ID: 3058789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical (behavior scale items), electrophysiologic (conditioned evoked potentials) and biochemical (urinary homovanillic acid) markers in infantile autism].
    Barthelemy C; Martineau J; Bruneau N; Garreau B; Jouve J; Muh JP; Lelord G
    Encephale; 1985; 11(3):101-6. PubMed ID: 3896755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium.
    Tolbert L; Haigler T; Waits MM; Dennis T
    J Autism Dev Disord; 1993 Mar; 23(1):193-9. PubMed ID: 8463199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.